The prevalence and diversity of fungi in respiratory samples of cystic fibrosis patients – a Dutch, nationwide, prospective, multicentre study
T. Engel (Nijmegen, Netherlands), L. Slabbers (Nijmegen, Netherlands), C. De Jong (Nijmegen, Netherlands), W. Melchers (Nijmegen, Netherlands), F. Hagen (Nijmegen, Netherlands), P. Verweij (Nijmegen, Netherlands), P. Merkus (Nijmegen, Netherlands), J. Meis (Nijmegen, Netherlands)
Source: International Congress 2018 – Latest developments in cystic fibrosis
Session: Latest developments in cystic fibrosis
Session type: Poster Discussion
Number: 3410
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Engel (Nijmegen, Netherlands), L. Slabbers (Nijmegen, Netherlands), C. De Jong (Nijmegen, Netherlands), W. Melchers (Nijmegen, Netherlands), F. Hagen (Nijmegen, Netherlands), P. Verweij (Nijmegen, Netherlands), P. Merkus (Nijmegen, Netherlands), J. Meis (Nijmegen, Netherlands). The prevalence and diversity of fungi in respiratory samples of cystic fibrosis patients – a Dutch, nationwide, prospective, multicentre study. 3410
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019
Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018
Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020
Increasing bronchiectasis prevalence in Germany, 2009–2017: a population-based cohort study Source: Eur Respir J, 54 (6) 1900499; 10.1183/13993003.00499-2019 Year: 2019
A multicentre cohort study on the association between common markers of asthma and the incidence of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 295s Year: 2006
Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020
Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort Source: Eur Respir J, 57 (4) 2001160; 10.1183/13993003.01160-2020 Year: 2021
Development of antibiotic-resistance in P. aeruginosa obtained from bronchiectasis patients: a multicenter prospective observational study Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018
Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study Source: Eur Respir J, 59 (2) 2102275; 10.1183/13993003.02275-2021 Year: 2022
Predictors for detecting chronic respiratory diseases in population surveys: a pilot study for RESPIRE 4CCORD study Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020 Year: 2021
Etiology and clinical characteristics of bronchiectasis in Taiwan: a multi-center cohort study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Monitoring physical activity in COPD patients – a monocentric, prospective cohort study Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020
REALizing and improving management of COPD in China: A prospective observational study Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014
Characteristics of COPD patients from primary care enrolled in a prospective multicenter cohort study Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010